Related Experiment Video
Updated: Mar 1, 2026

12:09
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
10.4K
LacZ inducible, antigen/MHC-specific T cell hybrids
1Department of Molecular and Cell Biology, University of California, Berkeley 94720.
International Immunology
|March 1, 1994
Summary
Researchers developed a new lacZ assay to measure T cell activation, offering a faster, cost-effective method. This technique enables single T cell analysis for identifying novel T cell antigens.
Area of Science:
- Immunology
- Molecular Biology
- Reporter Gene Assays
Background:
- The interleukin-2 (IL-2) gene's NFAT enhancer element regulates gene expression in activated T cells.
- This regulatory element can be coupled to reporter genes like Escherichia coli lacZ.
- Previous work demonstrated the potential of NFAT-lacZ constructs for measuring T cell activation.
Purpose of the Study:
- To develop T cell hybrids that inducibly express lacZ.
- To establish a novel assay for detecting T cell receptor (TCR)-mediated activation.
- To provide a method for identifying unknown T cell antigens.
Main Methods:
- Generation of BWZ.36 and BWZ.36 CD8 alpha fusion partners by transfecting alpha-beta-BW5147 cells with an NFAT-lacZ construct.
- Fusion of these partners with normal T cells from immunized mice.
- Detection of lacZ activity in response to antigen/MHC complexes.
Main Results:
- Successfully generated T cell hybrids exhibiting specific lacZ induction.
- Demonstrated that lacZ activity correlates with antigen/MHC class II and MHC class I complex recognition.
- Showcased the lacZ assay as a simpler, faster, and more cost-effective alternative to traditional IL-2 assays.
- Highlighted the assay's capability to detect single T cell activation.
Conclusions:
- The NFAT-lacZ inducible T cell hybrid system provides a robust method for studying T cell activation.
- This assay facilitates the detection of rare antigen-presenting cells.
- The developed method serves as a foundation for expression cloning strategies to identify novel T cell antigens.
Related Concept Videos
Hybridoma Technology
18.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.0K
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
T Cell Activation and Clonal Selection
16.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.7K
B Cell Activation and Differentiation
17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K

